These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10197889)

  • 1. Megavitamin and dietary treatment in schizophrenia: a randomised, controlled trial.
    Vaughan K; McConaghy N
    Aust N Z J Psychiatry; 1999 Feb; 33(1):84-8. PubMed ID: 10197889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of megavitamin therapy on children with attention deficit disorders.
    Haslam RH; Dalby JT; Rademaker AW
    Pediatrics; 1984 Jul; 74(1):103-11. PubMed ID: 6234505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megavitamins for minimal brain dysfunction. A placebo-controlled study.
    Arnold LE; Christopher J; Huestis RD; Smeltzer DJ
    JAMA; 1978 Dec; 240(24):2642-3. PubMed ID: 712981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megavitamin and orthomolecular therapy of schizophrenia.
    Brown WT
    Can Psychiatr Assoc J; 1975 Mar; 20(2):97-100. PubMed ID: 1164702
    [No Abstract]   [Full Text] [Related]  

  • 5. An orthomolecular approach to the prevention and treatment of psychiatric disorders.
    Zell M; Grundmann O
    Adv Mind Body Med; 2012; 26(2):14-28. PubMed ID: 23341413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin homeostasis in the brain and megavitamin therapy.
    Pauling L
    N Engl J Med; 1977 Oct; 297(14):790-1. PubMed ID: 895817
    [No Abstract]   [Full Text] [Related]  

  • 7. Negative findings with megavitamins in schizophrenic patients: preliminary report.
    Ban TA; Lehmann HE; Deutsch M
    Commun Psychopharmacol; 1977; 1(2):119-22. PubMed ID: 342184
    [No Abstract]   [Full Text] [Related]  

  • 8. Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial.
    Berk M; Gama CS; Sundram S; Hustig H; Koopowitz L; D'Souza R; Malloy H; Rowland C; Monkhouse A; Monkhouse A; Bole F; Sathiyamoorthy S; Piskulic D; Dodd S
    Hum Psychopharmacol; 2009 Apr; 24(3):233-8. PubMed ID: 19330802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megavitamins and learning disorders: a controlled double-blind experiment.
    Kershner J; Hawke W
    J Nutr; 1979 May; 109(5):819-26. PubMed ID: 374692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthomolecular psychiatry: niacin and megavitamin therapy.
    Hawkins DR; Bortin AW; Runyon RP
    Psychosomatics; 1970; 11(5):517-21. PubMed ID: 5470684
    [No Abstract]   [Full Text] [Related]  

  • 11. The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial.
    Lerner V; Miodownik C; Gibel A; Sirota P; Bush I; Elliot H; Benatov R; Ritsner MS
    J Clin Psychiatry; 2013 Dec; 74(12):1224-32. PubMed ID: 24434091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial.
    Akhondzadeh S; Nejatisafa AA; Amini H; Mohammadi MR; Larijani B; Kashani L; Raisi F; Kamalipour A
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):1007-12. PubMed ID: 14499318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor.
    Lane HY; Lin CH; Green MF; Hellemann G; Huang CC; Chen PW; Tun R; Chang YC; Tsai GE
    JAMA Psychiatry; 2013 Dec; 70(12):1267-75. PubMed ID: 24089054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral disorders, learning disabilities and megavitamin therapy.
    LaPerchia P
    Adolescence; 1987; 22(87):729-38. PubMed ID: 2963502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study.
    Kane JM; D'Souza DC; Patkar AA; Youakim JM; Tiller JM; Yang R; Keefe RS
    J Clin Psychiatry; 2010 Nov; 71(11):1475-81. PubMed ID: 20816042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia.
    Akhondzadeh S; Gerami M; Noroozian M; Karamghadiri N; Ghoreishi A; Abbasi SH; Rezazadeh SA
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1810-5. PubMed ID: 18727948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a role for megavitamin therapy in the treatment of attention deficit hyperactivity disorder?
    Haslam RH
    Adv Neurol; 1992; 58():303-10. PubMed ID: 1414636
    [No Abstract]   [Full Text] [Related]  

  • 18. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S; Safarcherati A; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Megavitamin treatment of schizophrenia.
    Hoffer J
    Can Psychiatr Assoc J; 1975 Oct; 20(6):492-5. PubMed ID: 1104135
    [No Abstract]   [Full Text] [Related]  

  • 20. Sustained and "sleeper" effects of group metacognitive training for schizophrenia: a randomized clinical trial.
    Moritz S; Veckenstedt R; Andreou C; Bohn F; Hottenrott B; Leighton L; Köther U; Woodward TS; Treszl A; Menon M; Schneider BC; Pfueller U; Roesch-Ely D
    JAMA Psychiatry; 2014 Oct; 71(10):1103-11. PubMed ID: 25103718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.